pharmaceutical division

Kunshan Rotam Reddy Pharmaceutical is focused on providing healthcare solutions that have a positive impact on people's well-being. We manufacture innovative and affordable drugs to serve the health care needs of patients and their families with strong presence in Dermatology, Gastroenterology and Endocrinology.

The division is headquartered in KETDZ, Kunshan City, an investor-friendly special economic development zone with abundant infrastructure facilities and scientific talent, located 40 kilometers from Shanghai, the business capital of China.

Our formulation and Active Pharmaceutical Ingredient (API) manufacturing facility is GMP-approved. We are continually investing in technology advancements to enhance efficiency of operations and improve quality standards.

Our in-house research department specializes in new product development.  A team of highly qualified personnel is actively developing new products in the areas of Gastroenterology, Cardiology, Endocrinology, Dermatology and Rheumatology.  We have products at different stages of registration and will be able to offer a basket of products in focused specialty segments.

We also have our own well-established distribution network covering 18 provinces. Our products are available in several hospitals and drug stores throughout China.

A joint venture between Rotam Group of Canada, Dr. Reddy's Laboratories Ltd. of India and Kunshan Double Crane Pharmaceutical Co., Ltd. of China, KRRP was established in the year 2000 with a total investment of $27 million (USD).